4.6 Article

Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United States

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Article Otorhinolaryngology

Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer

Hugh A. J. Kim et al.

Summary: Numerous studies have shown that head and neck squamous cell carcinoma (HNSCC) outcomes differ among different races and ethnicities. This study found that Black patients with non-HPV-related tumors had poorer progression-free survival compared to White patients. The tumors of Black patients exhibited molecular differences, including copy number aberrations, methylation of SFRP1, and miRNA-mediated PRG4 silencing, which were associated with poor survival. These findings can help inform targeted treatment decisions to achieve equitable outcomes.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Article Oncology

Effect of an Antiracism Intervention on Racial Disparities in Time to Lung Cancer Surgery

Marjory Charlot et al.

Summary: Accountability for Cancer Care through Undoing Racism and Equity is associated with timelier lung cancer surgery and reduction of the racial gap in timely surgery.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Otorhinolaryngology

Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups

Derian B. Taylor et al.

Summary: This study investigated survival differences and nonclinical factors associated with stage of presentation among head and neck cancer patients belonging to racial and ethnic minority groups in the US. It found that non-Hispanic Black patients had the lowest survival rates, while Hispanic and Asian/Pacific Islander patients had lower risks of HNC-specific mortality.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

Article Oncology

A Contemporary Analysis of Racial and Ethnic Disparities in Diagnosis of Early-Stage Breast Cancer and Stage-Specific Survival by Molecular Subtype

Kristin M. Primm et al.

Summary: Disparities in breast cancer diagnosis and survival persist among different racial and ethnic groups, with significant differences observed in early stage diagnosis and survival rates. These findings have important implications for efforts to reduce inequalities and disparities in breast cancer.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Otorhinolaryngology

Decreased overall survival in black patients with HPV-associated oropharyngeal cancer

Siddharth Sheth et al.

Summary: This study revealed that black patients with HPV-associated OPSCC have lower overall survival compared to white patients, and while the racial disparity slightly decreased after adjusting for demographic, clinical, and socioeconomic variables sequentially, a statistically significant black race disparity still remained in the final adjustment set.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Sue S. Yom et al.

Summary: Reducing radiation treatment dose in patients with good-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma (OPSCC) could potentially improve the quality of life. The study showed that reducing radiation dose could achieve disease control and survival rates equivalent to standard chemoradiation.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics

Farhad Islami et al.

Summary: This study provides updated data on cancer incidence, mortality, and survival rates in the United States, finding that overall cancer incidence continues to increase in females, children, and adolescents, while overall death rates are declining, especially for lung cancer and melanoma. For several major cancer types, however, death rates are still increasing or declining at a slower pace.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Otorhinolaryngology

Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival

Hong Li et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)

Article Oncology

Suicide risk among cancer survivors: Head and neck versus other cancers

Nosayaba Osazuwa-Peters et al.

CANCER (2018)

Article Otorhinolaryngology

Decreased cancer-independent life expectancy in the head and neck cancer population

Sean T. Massa et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)

Review Oncology

Human papillomavirus-related oropharyngeal cancer

M. Taberna et al.

ANNALS OF ONCOLOGY (2017)

Article Oncology

Treatment delays, race, and outcomes in head and neck cancer

Arash O. Naghavi et al.

CANCER EPIDEMIOLOGY (2016)

Article Oncology

Race and competing mortality in advanced head and neck cancer

Kaveh Zakeri et al.

ORAL ONCOLOGY (2014)

Article Otorhinolaryngology

DETERMINANTS OF HEAD AND NECK CANCER SURVIVAL BY RACE

Camille C. Ragin et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)

Article Oncology

Population-Based Study of Competing Mortality in Head and Neck Cancer

Brent S. Rose et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Medicine, General & Internal

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, Research & Experimental

Racial disparities in patients with head and neck squamous cell carcinoma

Christine G. Gourin et al.

LARYNGOSCOPE (2006)

Article Oncology

Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer

KK Ang et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)